Actively Recruiting
A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging
Led by Xijing Hospital · Updated on 2025-03-03
120
Participants Needed
1
Research Sites
212 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, open-label, single-center clinical study targeting hematological malignancies. 120 patients with a confirmed by pathology of non-Hodgkin's lymphoma or myeloma were included. Qualified subjects will undergo 18F-FDG PET/CT and 68Ga-Pentixafor PET/CT examination. The aim is to To investigate whether 68Ga-pentixafor PET imaging can be used as a reliable complement to 18F-FDG PET imaging for clinical staging, treatment response evaluation, and re-staging of patients with hematological malignancies.
CONDITIONS
Official Title
A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ages 18 to 75 years old
- Confirmed by pathology with non-Hodgkin's lymphoma or myeloma
- Willing and able to follow the study protocol
You will not qualify if you...
- Children, pregnant or lactating women
- Severely impaired liver and kidney function (alanine aminotransferase > 8-10 times normal, serum creatinine 186-442 umol/L)
- History of allergy to contrast media or other drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department ofNuclear Medicine,Xijing Hospital, Fourth Military Medical University
Xi'an, Shaanxi, China, 710000
Actively Recruiting
Research Team
Y
Ying Guo
CONTACT
X
Xuebing Yu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SEQUENTIAL
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here